Skip to content

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Deep Learning OCT and OCTA Quantification in Neovascular Age Related Macular Degeneration

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05969418
Acronym
OCTA
Enrollment
50
Registered
2023-08-01
Start date
2023-07-01
Completion date
2023-12-21
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Degeneration Choroidal Neovascularization

Brief summary

To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.

Detailed description

Exudative neovascular macular degeneration is the primarily an age-related retinal condition The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features in order to choose the best therapy . The study evaluates the changes in structural optical coherence tomography and optical coherence tomography angiography features in neovascular macular degeration patients undergoing ANTI-VEGF treatments using artificial intelligence.

Interventions

DIAGNOSTIC_TESTDiagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter

Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter before and after ANTI-VEGF treatment

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

age older than 50 years * diagnosis of neovascular macular degeneration * absence of previous retinal surgery and congenital eye diseases. * absence of errors of refraction * absence of lens opacities * absence of low-quality OCT and OCTA images

Exclusion criteria

• age younger than 50 years * previous retinal surgery and congenital eye diseases * errors of refraction * lens opacities * low-quality OCT and OCTA images

Design outcomes

Primary

MeasureTime frame
The measurements of retinal and choriocapillary vessel density in patients with macular degeneration complicated by nvcmore than sixmonths

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026